25
Oct
2018
Large-scale cancer study locates “light switches” in the “dark” regions of the genome
/
Many of cancer’s long-buried secrets are now out in the open thanks to a collaborative effort to catalog the genetic switches that... Read More
5
Apr
2018
Comprehensive atlas redefines gastrointestinal cancers
/
Scientists now have a powerful new resource for developing better treatments for common cancers of the esophagus, stomach, colon and rectum, collectively... Read More
5
Apr
2018
Van Andel Research Institute scientists help redefine how cancer is categorized
Comprehensive scientific resource highlighted in more than two dozen papers published in Cell Press by The Cancer Genome Atlas
/
Laird is senior author on the paper, along with Adam J. Bass, M.D., of Harvard University and Dana-Farber Cancer Institute, and Vésteinn... Read More
2
Apr
2018
21
Jun
2017
Research brief: Developing a “roadmap” for the second deadliest cancer worldwide
/
Scientists have a new tool to tackle the second leading cause of cancer death, thanks to work from The Cancer Genome Atlas... Read More
14
Mar
2017
Research brief: Four molecular subtypes revealed in rare bile duct cancer
/
The short version Scientists now have a new resource for studying a rare bile duct cancer that may serve as a blueprint... Read More
17
Nov
2016
Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis
/
GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from... Read More
5
Nov
2015
TCGA findings provide molecular background for second most common kidney cancer
/
GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have molecularly characterized two... Read More